These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32810863)

  • 1. Systemic Inflammation Is Associated with Oncological Outcome in Patients with High-Grade Myxofibrosarcoma of the Extremities: A Retrospective Analysis.
    Sambri A; Zucchini R; Giannini C; Cevolani L; Fiore M; Spinnato P; Bianchi G; Donati DM; De Paolis M
    Oncol Res Treat; 2020; 43(10):531-538. PubMed ID: 32810863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading in Myxofibrosarcoma of the Extremities Can Predict Survival and Local Control.
    Sambri A; Tuzzato G; Spinnato P; De Paolis M; Donati DM; Bianchi G
    Oncol Res Treat; 2020; 43(5):189-195. PubMed ID: 32268331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does pre-operative MRI predict the risk of local recurrence in primary myxofibrosarcoma of the extremities?
    Sambri A; Spinnato P; Bazzocchi A; Tuzzato GM; Donati D; Bianchi G
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e181-e186. PubMed ID: 31111597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soft tissue myxofibrosarcoma: A clinico-pathological analysis of a series of 75 patients with emphasis on the epithelioid variant.
    Scoccianti G; Ranucci V; Frenos F; Greto D; Beltrami G; Capanna R; Franchi A
    J Surg Oncol; 2016 Jul; 114(1):50-5. PubMed ID: 27076198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
    Huang HY; Lal P; Qin J; Brennan MF; Antonescu CR
    Hum Pathol; 2004 May; 35(5):612-21. PubMed ID: 15138937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival.
    Lin CN; Chou SC; Li CF; Tsai KB; Chen WC; Hsiung CY; Yen CF; Huang HY
    J Surg Oncol; 2006 Mar; 93(4):294-303. PubMed ID: 16496357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
    Choi ES; Kim HS; Han I
    Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of clinical factors impacting recurrence in myxofibrosarcoma.
    Chen W; Ye M; Sun Y; Wei Y; Huang Y
    Sci Rep; 2024 Feb; 14(1):3903. PubMed ID: 38365844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and outcomes of patients with myxofibrosarcoma.
    Look Hong NJ; Hornicek FJ; Raskin KA; Yoon SS; Szymonifka J; Yeap B; Chen YL; DeLaney TF; Nielsen GP; Mullen JT
    Ann Surg Oncol; 2013 Jan; 20(1):80-6. PubMed ID: 22890594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Local Recurrence in Patients With Myxofibrosarcoma.
    Odei B; Rwigema JC; Eilber FR; Eilber FC; Selch M; Singh A; Chmielowski B; Nelson SD; Wang PC; Steinberg M; Kamrava M
    Am J Clin Oncol; 2018 Sep; 41(9):827-831. PubMed ID: 28640064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
    Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
    Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 in relation to early recurrence in primary, localized soft tissue sarcoma: An addition for existing risk classification systems?
    van der Laan P; van der Graaf WTA; van den Broek D; van Boven H; Heeres BC; Schrage Y; Haas RL; Steeghs N; van Houdt WJ
    Eur J Surg Oncol; 2024 Sep; 50(9):108530. PubMed ID: 39083882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
    Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
    World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI Features as Prognostic Factors in Myxofibrosarcoma: Proposal of MRI Grading System.
    Spinnato P; Clinca R; Vara G; Cesari M; Ponti F; Facchini G; Longhi A; Donati DM; Bianchi G; Sambri A
    Acad Radiol; 2021 Nov; 28(11):1524-1529. PubMed ID: 32928636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinicopathologic examination of myxofibrosarcoma. Do surgical margins significantly affect local recurrence rates in this infiltrative sarcoma subtype?
    Dadrass F; Gusho C; Yang F; Culvern C; Bloom J; Fillingham Y; Colman M; Gitelis S; Blank A
    J Surg Oncol; 2021 Feb; 123(2):489-496. PubMed ID: 33125727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer.
    Seong MK
    J Korean Med Sci; 2015 Dec; 30(12):1793-9. PubMed ID: 26713054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
    Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
    Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy.
    Boughzala-Bennadji R; Stoeckle E; Le Péchoux C; Méeus P; Honoré C; Attal J; Duffaud F; De Pinieux G; Bompas E; Thariat J; Leroux A; Bertucci F; Isambert N; Delcambre C; Blay JY; Sunyach MP; Coindre JM; Sargos P; Penel N; Bonvalot S
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):399-406. PubMed ID: 30191871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma.
    Nakamura T; Matsumine A; Matsubara T; Asanuma K; Yada Y; Hagi T; Sudo A
    PLoS One; 2017; 12(7):e0181787. PubMed ID: 28727824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant.
    Mentzel T; Calonje E; Wadden C; Camplejohn RS; Beham A; Smith MA; Fletcher CD
    Am J Surg Pathol; 1996 Apr; 20(4):391-405. PubMed ID: 8604805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.